一个免疫纳米增强剂使化疗药物恢复活力,为抗癌免疫工程量身定制瘤衍生的dDNA
Yiming Liu1, Yachao Li1,2, Wensheng Gong1
1Peptide Biomedicine Laboratory (PBL), College of Biology, Hunan University, Changsha, Hunan, China.
Advanced materials (Deerfield Beach, Fla.)
|December 24, 2025
概括
一个新的纳米增强剂平台重新编程化疗以激活cGAS-STING通路,增强抗瘤免疫力. 这种方法可以增强免疫细胞的活动和记忆力,为癌症免疫治疗提供了一种新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 目前的癌症免疫疗法往往针对癌症免疫循环中的单个步骤,限制了持久的临床成功.
- cGAS-STING通路对于免疫监测至关重要,但缺乏安全有效的瘤双链DNA (dsDNA) 诱导剂来激活它.
- 化疗激活这种途径的潜力仍然未被充分探索,因为在诱导足够的dsDNA方面存在挑战.
研究的目的:
- 开发一个平台,重编程现有的化疗药物,以激活瘤内的cGAS-STING通路.
- 增强瘤衍生的dSDNA的积累和免疫性释放,以持续免疫激活.
- 为改善基于STING的免疫疗法和癌症治疗制定临床相关的战略.
主要方法:
- 设计了一个免疫纳米增强剂平台 (C-iNE/A),用于封装化疗药物.
- 利用机器学习来优化药物输送,并将其与轻度高温症相结合,以损害DNA修复.
- 研究了该平台在临床前模型中诱导dSDNA积累,免疫细胞透和抗瘤反应的能力.
主要成果:
- 在瘤中,C-iNE/A成功地激活了cGAS-STING信号传递,即使在低剂量的化疗中也是如此.
- 该平台促进了内dDNA的积累和释放,从而提高了免疫活性.
- 在各种瘤模型中显著改善了树突细胞成熟,细胞毒性T淋巴细胞透,转移抑制和记忆T细胞生成.
结论:
- C-iNE/A平台提供了一种可通用的方法,将传统的化疗药物转化为强大的免疫激活剂.
- 这种方法克服了当前基于STING的免疫疗法的局限性,通过利用安全的药物剂量和增强免疫反应.
- 这项研究为下一代瘤免疫调节疗法提供了一个有希望的,临床相关的策略.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K